US 10941135
Nrf2 activating compounds and uses thereof
granted A61PA61P17/06A61P25/00
Quick answer
US patent 10941135 (Nrf2 activating compounds and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P17/06, A61P25/00, A61P29/00, A61P37/02